TAKEDA PHARMACEUTICALS U.S.A., INC., f/k/a Takeda Pharmaceuticals North America, Incorporated | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for TAKEDA PHARMACEUTICALS U.S.A., INC., f/k/a Takeda Pharmaceuticals North America, Incorporated

Sort by

Viewing results 1‒25 of 25

Pharmaceuticals sector
Health care stocks fall after Trump comments on drug pricing
...Japanese prescription drug maker Astellas Pharma, a company that derives a third of its revenue from North America, according to Bloomberg data, tumbled 3.9 per cent....
January 12, 2017
US politics & policy
Drug stocks tumble as Trump singles out pharma companies
...The S&P 500 index was off by 0.1 per cent, reversing a rise of as much as 0.3 per cent....
January 12, 2017
FT Live
Managing Operational Risk in M&A Transactions
Examining the value of business licensing and property tax in the deal cycle
Thursday, 20 JuneDigital Conference
News in-depthUK companies
GSK and AstraZeneca prescribe different treatments
...This has left the company’s share price almost unchanged over the period while the S&P pharmaceuticals index has doubled....
January 3, 2016
US & Canadian companies
Week in Review, March 21
...But by Thursday the company was forced into an embarrassing retraction, with Michael O’Leary apologising and saying Ryanair had “f****** up”....
March 20, 2015
FT AlphavilleDavid Keohane
The 6am London Cut
...(Financial Times) “A U.S. jury ordered Takeda Pharmaceutical Co Ltd to pay $6 billion in punitive damages and Eli Lilly and Co to pay $3 billion in a case claiming that cancer risks to the diabetes drug...
April 8, 2014
FT AlphavilleDavid Keohane
The 6am London Cut
...(Financial Times) (NYT) “A U.S. regulator filed lawsuits against Morgan Stanley and eight other banks over the sale of nearly $2.4 billion in mortgage-backed securities to two credit unions that later failed...
September 24, 2013
FT Live
FTWeekend Festival: U.S. edition
The Saturday where the Financial Times Weekend paper comes to life
Saturday, 10 May 2025The REACH, at the Kennedy Center for the Performing Arts, F Street Northwest, Washington, DC, USA
US & Canadian companies
Sandoz gains dermatology lead with Fougera
...But when the firms sold Nycomed to Takeda Pharmaceutical for $13.7bn last year, they kept Fougera....
May 2, 2012
Asia-Pacific equities
Asia mixed after China easing
...Takeda Pharmaceutical plunged 3.2 per cent to Y3,290 as investors were disappointed by the drugmaker’s operating profit forecast for this fiscal year....
May 14, 2012
US & Canadian companies
Astellas in $1.4bn cancer treatment deal
...The Aveo agreement covers the development of the drug and its commercialisation in North America and Europe. The companies will share the profits equally....
February 17, 2011
FT AlphavilleGwen Robinson
Sanofi-Genzyme: end of a saga?
...From Market Watch: French pharmaceuticals major Sanofi-Aventis SA confirmed Wednesday it has struck a deal to buy U.S. peer Genzyme Corp....
February 16, 2011
IPOs
Deal activity fails to boost US stocks
...Genzyme which makes treatments for rare genetic conditions, advanced 0.3 per cent to $70.03 after it was reported that it had started talks with Japanese company Takeda Pharmaceutical about a possible deal...
November 15, 2010
World
Pharma stocks rise after Republican Senate win
...Takeda Pharmaceutical, which is Asia’s biggest drugmaker and receives 41 per cent of sales in North America, added 1.7 per cent to Y40.00....
January 20, 2010
Asia-Pacific equities
Asia-Pacific markets extend the rally
...Takeda Pharmaceutical rose by 3.7 per cent to Y3,650, although news that regulators had approved its diabetes drug for new applications came after the market close....
March 24, 2009
Asia-Pacific equities
Financial stocks lead Asian dip
...Takeda Pharmaceutical, Japan’s biggest drugs company, fell 13.1 per cent to Y3,320 after US regulators said they needed more information to approve or reject a new medicine, raising the prospects of lengthy...
March 9, 2009
US downturn
Hong Kong boosts Asia-Pacific markets
...Japan’s largest pharmaceutical company Takeda, lost 3.9 per cent to Y3,190. Chugai Pharmaceutical fell 5.9 per cent to Y1,552....
March 10, 2009
FT Live
Future of Asset Management North America
New models for the next age of fund management
Wednesday, 25 SeptemberNew York, NY, USA
US & Canadian companies
Takeda bids $8.8bn for Millennium
...Shares of Takeda Pharmaceutical opened lower on Friday, down 3.7 per cent (Y5,210), after the Osaka-based company announced it was buying Millennium Pharmaceuticals, a US biotechnology company with an approved...
April 11, 2008
Central banks
Asian shares boosted by interest rate cuts
...Takeda Pharmaceutical dropped 5.5 per cent to a 52-week low of Y4,660 as the company said cuts in the price of drugs would affect domestic sales....
October 9, 2008
US downturn
Asia rallies as Wall Street finds its feet
...Drug companies were some of the strongest performers on the Nikkei, with Astellas Pharma rallying 4.5 per cent to Y4,640, Takeda Pharmaceutical gaining 3.6 per cent to Y5,520....
July 30, 2008
US downturn
Westpac talks spur bank gains
...The Nikkei’s gains were bolstered by Japan’s largest pharmaceutical company Takeda, which on Friday announced a near-$1bn share buyback, helped shares rally 3.5 per cent to Y5,680....
May 12, 2008
Oil
Asian markets mixed as oil retreats
...Takeda Pharmaceutical gained 2.8 per cent to Y5,910 and Astellas Pharma rose by 1.9 per cent to Y4,340. Oil companies gave up some of their gains made earlier this week when the price of oil surged....
May 23, 2008
Semiconductors
Japan property groups hit by downgrades
...Takeda Pharmaceutical, one of Japan’s largest drug companies, said it would buy US rival Millennium Pharmaceuticals in a deal worth $8.8bn. Takeda shares fell 2.5 per cent to Y5,410....
April 10, 2008
European banks
Tighter monetary policy hits Asian shares
...Elsewhere, Takeda Pharmaceutical and other drugmakers lost ground on newspaper reports that the government plans to cut medical costs by more than 1 per cent next fiscal year....
December 17, 2007
Asia-Pacific equities
Asian stocks take a breather ahead of New Year break
...Takeda Pharmaceutical, Japan's biggest drug maker, finished flat at Y4,900 after announcing on Monday that it would buy Syrrx, a US bio-tech venture....
February 8, 2005
Asia-Pacific equities
Dollar weakness weighs on Asian stocks
...Takeda Chemical Industries, Japan's biggest drug maker, fell 3.2 per cent to Y5,090 while Yamanouchi Pharmaceutical dropped 3.5 per cent to Y3,870....
November 22, 2004
Investment Banking
Kerry displays business credentials in swipe at Bush
...Geschke, Founder and Chairman, Adobe Systems, Inc. Charles K. Gifford, Chairman, Bank of America Corporation Rob Glaser, Founder, Chairman and CEO, RealNetworks, Inc. Donald J....
August 4, 2004

Previous pagePage 1 of 1Next page